Sundram F
Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, 22 Park Avenue, Grafton, Auckland 1023, New Zealand. Electronic address: f.sundram@auckland.ac.nz.
ArticleLSD
LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial.
ArticleLSD
What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial.
ArticleLSD
LSD microdosing in major depressive disorder: results from an open-label trial.
ArticleLSD
Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures.
ArticleLSD
Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide.
ArticleLSD
LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.
ArticleLSD
LSD increases sleep duration the night after microdosing.
ArticleLSD
PAM trial protocol: a randomised feasibility study of psychedelic microdosing-assisted meaning-centred psychotherapy in advanced stage cancer patients.
ArticleLSD
An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).
ArticlePsychedelics
Cancer Healthcare Workers' Perceptions toward Psychedelic-Assisted Therapy: A Preliminary Investigation.
ArticleLSD